Background study of HIV-1 drug resistant mutations in treatment-naïve patients in Liaoning province

Acta Academiae Medicinae Sinicae

Volumn 28, Issue 5, 2006, Pages 632-636

  Han, Xiao Xu ^a   Zhang, Min ^a   Dai, Di ^a   Lu, Chun Ming ^a,b   Zhang, Zi Ning ^a   Liu, Jing ^a   Wang, Ya Nan ^a   Jiang, Yong Jun ^a   Shang, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Provincial Center for Disease Control and Prevention   (China)

Author keywords

Drug resistance; Genotype; Human immunodeficiency virus

Indexed keywords

AMINO ACID; ANTIRETROVIRUS AGENT; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CHINA; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC DISTANCE; GENOTYPE; GEOGRAPHIC ORIGIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NONHUMAN; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; VIRUS RESISTANCE; VIRUS STRAIN;

ADULT; CHINA; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 37549068290     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Metzner KJ, Rauch P, Walter H, et al. Detection of minor populations of drug resistant HIV-1 in acute seroconverters. AIDS, 2005, 19(16):1819-1825.
2. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med, 2002, 347(6):385-394.
3. Chin-Hong PV, Deeks SG, Liegler T, et al. High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. J Acquir Immune Defic Syndr, 2005, 40(4):463-471.
4. Danutaa P, Marka R, Dale H, et al. Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. AIDS, 2000, 14(11):1489-1495.
5. Montes B, Vergne L, Peeters M, et al. Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. J Acquir Immune Defic Syndr, 2004, 35(4):329-336.
6. Holguin A, Sune C, Hamy F, et al. Natural polymorphisms in the protease gene modulate the replicative capacity of non-B HIV-1 variants in the absence of drug pressure. J Clin Virol, 2006, 36(4):264-271.
7. Arivoshi K, Matsuda M, Miura H, et al. Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01Æ (subtype E) infection differ from subtype B infection. J Acquir Immune Defic Syndr, 2003, 33(3):336-342.
8. Kantor R, Katzenstein DA, Efron B, et al. Impact of HIV-1 sub-type and antiretroviral therapy on protease and reverse transcriptase genotype : results of a global collaboration. PLoS Med, 2005, 2(4):e112.